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An in vitro model system using cultured newborn epi-
dermal cells was employed to investigate the binding of 
pemphigus autoantibody and subsequent loss of adhe-
sion between epidermal cells. Pemphigus antibodies 
bound to both mouse and human cultured epidermal 
cells . Incubation of cultured newborn mouse epidermal 
cells with pemphigus antibody followed by gentle agi-
tation induced loss of adhesion between the epidermal 
cells and the plastic culture dish. Release of viable epi-
dermal cells from the dish was inhibited by the protein-
ase inhibitors, soybean trypsin inhibitor and alpha2-mac-
roglobulin. These observations suggest that pemphigus 
antibody induces viable epidermal cells to activate cel-
lular proteinases which then degrade the glycocalyx and 
cause cellular dyshesion and acantholysis. 
Pemphigus is characterized by the production of circulating 
autoantibodies directed against the surface of human epidermal 
cells [1, 2). The ultimate result of the binding of pemphigus 
antibody to the surface of epidermal cells is a loss of adhesion 
between cells which causes acantholysis. Michel and co-workers 
[3, 4] and others [5, 6] have shown that explants of whole 
human skin incubated in the presence of serum from pemphigus 
patients develop acantholysis of the basal epidermal cells. This 
in vitro acantholysis occurs in the absence of complement. It is 
difficult to quanititate acantholysis in organ culture and to 
evaluate the biochemical changes induced in epidermal cells by 
binding of pemphigus antibodies. Subsequent investigations by 
Schiltz and Michel [7) and Schiltz et al [8) utilized epidermal 
cells in suspension culture to elucidate the pathophysiological 
events in pemphigus vulgaris. Unfortunately, epidermal cell 
suspensions have very limited viability [9] and lack cell-to-cell 
contact; disruption of cell -to-cell adhesion is an integral aspect 
of the pathophysiology of pemphigus. For the past 3 yr we have 
used epidermal cell culture techniques to investigate the mech-
anism of loss of adhesion between epidermal cells in pemphigus 
vulgaris. We have shown that incubation of newborn mouse 
epidermal cells in tissue culture with pemphigus antibody in-
duces loss of adhesion between epidermal cells and the plastic 
culture dish [10). Release of viable epidermal cells from the 
culture plate by pemphigus immunoglobulin is prevented by 
the addition of serine proteinase inhibitors. These inhibitors do 
not prevent binding of pemphigus antibody to the epidermal 
cells. These data suggest that pemphigus antibody induces 
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viable epithelial cells to activate cellular proteinases which then 
degrade the glycocalyx and induce cellular dyshesion and acan-
tholysis. 
MATERIALS AND METHODS 
Sera 
Pemphigus sera were obtained from Ernst Beutner (Buffalo, N.Y.) 
J ean Claude Bystryn (New York, N.Y.), Robert Jordon (Milwaukee, 
Wi.), Steven Katz (Bethesda, Md.), Thomas Provost (Baltimore, Md.), 
and Ronald Reisner (Los Angeles, Ca. ). Pemphigus sera were t itered 
for ant i-epidermal-cell antibody by standru·d immunofluorescent tech-
niques and had titers ranging from 1:160 to 1:640. Bullous pemphigoid 
sera were t itered against monkey esophagus and had titers of 1:1240 of 
ant i-basement membrane ant ibody. Normal contro l sera were obtained 
from healthy adult donors. All sera were stored at -20° and they were 
heated at 56° for 30 min prior to use. 
Epidermal Cell Cultures 
Neonatal mouse epidermal cell cultures were prepared by the method 
of Elgjo et a l [11]. Briefly, skin removed from 24-48 hr-old BALB/ c 
mice was treated wi th 0.25% trypsin (Type Ill, S igma, St. Louis, Mo.) 
for 18 hr at 4° to separate the dermis and epidermis. The epidermis 
was minced and mechanically agitated to obtain a cell suspension. A 
fraction containing pmified, viable epidermal cells was collected after 
centrifugation on a discontinous Ficoll (Sigma) gradient. Cells were 
then plated onto 35-mm t issue cultme dishes (6 X 10'' cells/ dish) in 
Medium 199 (GIBCO, Grand Island, N.Y.) supplemented with heat 
inactivated fetal calf serum (GIBCO) to a final concentration of 15%. 
Human epidermal cells from newborn foreskins were cul tured using 
a modification of the technique of Rheinwald and Green [12). Tissue 
was obtained within 3 hr of circumcision and incubated briefly in 
antibiotic containing medium. After removal of fatty t issue, the foreskin 
was placed epidermal side down in 0.25% trypsin (Sigma) and incubated 
at 37° for 3 hl". The e"pidermis was then easily removed from the dermis, 
teased with forceps to obtain a single cell suspension and ftltered 
through nylon mesh. The cells (1-6 X lOG total) were plated into a 75 
cm
2 tissue cult ure flask which had previously received gamma irradiated 
mouse 3T3 fibroblasts (CCL 92, American Type Culture Collection, 
Rockville, MD) . Human epidermal cells were grown in an enriched 
medium [Dulbecco's Modified Eagle's Medium (GIBCO) supplemented 
with fetal calf serum (Irvine Scientific, San ta Ana, CA) to a final 
concentration of 20%, 20 ng/ ml epidermal growth factor (Collaborative 
ReseaTch, Waltham, MA) , 0.4 ttg/ ml hydrocortisone (Sigma), 10- '" M 
cholera toxin (Schwartz-Mann, Orangeburg, NY), 100 units/ ml penicil -
lin and 100 l!g/ ml streptomycin]. Cultmes were usually 70-90% con-
fluent within 2 weeks and were subcultw·ed once before immunoflu o-
rescence or detachment experiments were performed. 
Immunofluorescence Studies 
Binding of pemphigus lgG to epidermal ce ll surface was demon-
strated by indirect immunofluorescence techniques using viable cells 
grown on glass cover slips. Pemphigus, pemphigoid, and normal sera 
were dilu ted with PBS conta ining 4% bovine serum a lbumin (Sigma) to 
1:25, 1:50, 1:100, and 1:200. The sera were applied to cells for 30-60 min 
at 25°. The cover slips were then washed 4 times with PBS conta ining 
bovine serum albumin. In the second step, rhodamine-conjugated goat 
an ti-human l gG (Cappel Laboratories, Downington, PA), that had been 
adsorbed with bovine liver powder (Sigma) and diluted 1:64 (vol/vol) 
with albumin in PBS, was applied for 30- 60 min. The cover slips were 
then washed 4 times with albumin in PBS and placed onto a drop of 
glycerol/PBS on a clean glass microscope slide. The specimens were 
examined at 580 nm (magnification X 630) with a Zeiss lru·ge universal 
flu orescence microscope with a !!IRS vertical illuminator. 
364 SINGER ET AL 
Detachment Studies 
The cell cultures used to study immunoglobulin-mediated detach-
ment of neonatal mouse epidermal cells were incubated with 1 j.tCi of 
"H-thymidine per 8 cm2 culture dish during the initial 24-hr plating 
period. The cultures were then washed with 4 changes of PBS to 
remove unbound radioactive label and fetal calf serum. Cells were then 
incubated in 1.25 ml Medium 199 containing heat inactivated (56° , 30 
min) 1:50 dilutions of pemphigus serum, pemphigoid serum or normal 
human serum. In some experiments the medium also contained soybean 
trypsin inhibitor (Sigma, 100 j.tg/ml) (SBTI) or purified alpha2-macro-
globulin (0.5 mg/ ml) (a2M). After incubation for 8, 24 or 48 hr at 35° in 
a humid atmosphere of 5% CO, in air, the cells were gently washed 
with their overlying medium 15 t imes by aspiration with a pasteur 
pipette. The medium was removed, filtered onto Whatman GF /C ftlters 
and ftlters were washed extensively with PBS followed by trichloroace-
tic acid (TCA). The filters were then assayed for radioactivity. TCA 
precipitable radioactivity in the medium was taken to represent de-
tachable cells. The plates were scraped with a rubber policeman and 
the contents were filtered and treated as described for the medium. 
The TCA precipitab le radioactivi ty remaining on the plate was taken 
to represent adherent cells. Cell detachment was expressed as the 
percent of precipitable radioactivity present in the medium. 
Viability of the epidermal cell cultures after incubation with pem-
phius serum or normal human serum for 8, 24 or 48 hr was determined 
by incubating parallel cultures with 14C-amino acids and measuring the 
production of 14C labeled TCA precipitable protein. 
RESULTS 
Indirect immunofluorescence studies on viable cultured cells 
demonstrated that immunoglobulin fTom pemphigus patients 
binds to the surface of mouse epidermal cells while normal 
human serum does not bind to the mouse cells (Fig 1). Similar 
observations were made when cultmed human foreskin epider-
mal cells were studied. 
Epidermal cells incubated in the presence of pemphigus 
serum detached from the culture plates to a significantly weater 
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extent than did cells incubated with normal serum (Fig 2). 
Pemphigus-induced cell detachment was twice the control 
levels at 8 hr and detachability increased throughout the 48-hr 
culture period. Identical results were obtained when epidermal 
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FIG 2. Detachability of epidermal cells from culture plates incu-
bated with pemphigus serum (1:50) , pemphigoid serum (1:50) , or normal 
serum (1:50) as a function of time. Detachment was measured as the 
amount of trichloroacetic acid-precipitable ("H)thymidine in the me-
dium as a percentage of the total radioactivity in the medium and on 
the cultUJ·e plate, shown as mean. 
FIG 1. Binding of pemphigus antibody to the periphery of mouse epidermal cells in culture. (Left) Cells incubated with pemphigus serum (1: 
50) fo llowed by rhodamine-conjugated goat anti-human lgG. (Right) Same batch of epidermal cells incubated with normal human serum (1:50) 
followed by goat anti-human IgG (X 460). 
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FIG 3. Detachability of epidermal cells from culture plates incu-
bated with pemphigus serum (1:50), pemphigus serum (1:50) plus 
soybean trypsin inhibitor at 100 11/ ml, and normal serum (1 :50) as a 
function of t ime. Detachment was measw-ed as the am ount of t richloro-
acetic ac id-precipitable e H) thymidine in the medium as a percentage 
of the total radioactivi ty in the medium a nd on the culture plate, shown 
as mean. 
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FI G 4. Incorporation of 14C-labeled amino ac ids into trichloroacetic 
acid-precipitable protein in ce lls incubated with pemphigus serum (1: 
50) (P) , or normal serum (1:50) (N) as a function of t ime, shown as 
mean± SEM. 
cells were incubated with preparations of partially purified IgG 
. from pemphigus patients. High t iter bullous pemphigoid serum, 
which contains an anti-epidermal basement membrane anti-
body induced only slightly more cellular detachment than 
normal control serum (Fig 2). 
Pemphigus serum-induced epidermal cell detachment was 
blocked by the addit ion of the proteinase inhibitor soybean 
trypsin inhibitor (Fig 3). Identical r esults were obtained when 
the broad spectrum proteinase inhibitor alpha2-macroglobulin 
was used. These proteinase inhibitors did not prevent binding 
of pemphigus antibody to mouse epidermal cells. 
The pemphigus serum-induced detachment of epidermal cells 
was not a result of cell death. Parallel cultures of epidermal 
cells incubated with normal human serum or pemphigus serum 
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had equal ability to synth esize TCA precipitable protein from 
14C-amino uptake dming the 48 hr culture period (Fig 4). 
DISCUSSION 
Patients with pemphigus vulgaris demonstrate unique fragil-
ity of the skin. Normal-appearing epidermis can be induced to 
blister with trivial trauma. Electron microscopy of affected 
epidermis reveals that the first ultrastructural ch a nge is loss of 
the glycocalyx between viable appearing epidermal cells [13]. 
This change correlates with deposition of pemphigus autoanti-
body. These clinical and pathological observations argue 
strongly against the hypothesis that pemphigus autoantibody 
induces acantholysis by cytolysis of epidermal cells. Rather 
these observations suggest that pemphigus antibody causes 
viable epidermal cells to alter their glycocalyx cement sub-
stance. One mechanism for loss of glycocalyx would be an 
inhibition of synthesis; there is no evidence at present to support 
such an hypothesis. The second mechanism would be specific 
degradation of the glycocalyx induced by binding of pemphigus 
antibody to viable epidermal cells . Our data support this hy-
pothesis. We have shown that pemphigus antibody binds to 
human and mouse epidermal cells in cul tme. Binding of the 
pemphigus antibody induces a time and a dose dependent loss 
of adhesion between epidermal cells. The cells rem ain viable 
and attached to the dish but gentle agitat ion of th e cultme 
medium releases the cells from the substratum. These events 
exactly reflect the clinical observations. The observation that 
dyshesion is inhibited by addition of proteinase inhibitors to 
the epidermal cells cultured with pemphigus antibody implies 
that pemphigus antibody induces viable epidermal cells to 
activate proteinase. 
Utilizing our human epidermal cell cultme system we are 
identifying the exact hydrolases responsible for dissolution of 
the glycocalyx. We are also establishing the species of macro-
molecules cleaved when epidermal cells are incubated with 
pemphigus l gG. 
Preliminary experiments with a variety of cell lines and 
specific anticell surface antibodies suggests that proteinase ac-
tivation and loss of cellular adhesion may be a common phe-
nomenon. Such an observation would have broad biological 
interest because it would suggest mechanisms by which m em-
brane directed antibodies influence cells. 
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PANEL DISCUSSION 
Mechanisms of Acantholysis in Pemphigus 
MODERATOR: Thomas Provost 
Drs. Robert Jordon, John Schil tz and Kay Singer 
WUEPPER: Is it possible to show cell killing with dispersed keratin-
ocytes, purified pemphigus IgG and a fresh source of complement? 
SCHILTZ: Yes, but the rates of killing by pemphigus IgG are similar 
in the presence or absence of complement , and loss of viability occurs 
only after several hours incubation. Takigawa and Imamura (J Invest 
Dermatol 68:259, 1977i similarly reported that pemphigus antibody and 
fresh complement does not lyse suspended human epidermal cells in 
short-term experiments, even though the antibody binds to the epider-
mal cell surface . I believe the living cells first respond to the antibody 
by producing the protease "pemphigus acantholysis fac tor," the agent 
which causes lysis. 
WUEPPER: Dr Singer, do you agree with that? 
S IN GER: I have not worked with dispersed keratinocytes and I have 
not added fresh complement back to the system, so I do not have any 
data. · 
WuEPPER: What about the possibility that the complex carbohydrate 
surface of the keratinocyte could activate complemen t direc tly, leading 
to some of the events mentioned? Obviously many carbohydrates will 
activate complement via the alternative pathway. 
JORDON: That is certainly possible, except that we see evidence of 
activation of the classical pathway as well, with deposit ion of C1q and 
C4 , in addition to C3. If you look at normal skin you find IgG deposition 
without complement deposition. In these areas you can elicit the 
Nikolsky sign, which suggests what has been said here, that is, the 
antibody itself is enough to induce the acantholytic process. However, 
it may be that in the acantholytic areas the antigens become so changed 
on the surface of the cell that we begin to see interaction of complement 
with some of the antibodies. 
KATZ: Dr. Schiltz, my in terpretation of that slide in your indirect 
immunofluorescence of the epidermal cells in suspension is that 70% of 
the cells are dead rather tha n binding antibody. Have you checked 
them for viability? 
ScHILTZ: If those cells were dead, as you suggest, it was an artifact 
of their preparation for immunofluorescence. Trypan blue exclusion 
experiments showed them to be 95% viable after 30 min incubation 
with pemphigus antibody. After 18 hr, roughly 14% of cells incubated 
with pemphigus antibody ar e viable as compared to about 75% of the 
controls incubated with normal IgG. In addition, accumulation of 
radiactive proteins by cells incubated with pemphigus antibody is 
quant itatively similar to controls during the first 2 hr. 
KATz: Dr. Singer, could you tell us the time course of the loosening 
of these cells, and if there is an optimal period? 
SINGER: The results shown are a composite of 12 different experi-
ments. By 8 hr you get about twice as many cells released with the 
pemphigus serum as opposed to the normal serum. I believe that the 
data was 30% versus 15% and it increases beyond that. We have not 
checked before 8 hr, but there is increased loosening of the cells through 
the 48-hr period tested. 
RAY: Is it conceivable that complement activation is due to the 
release of protease activity and not pemphigus antibody since comple-
ment deposition occurs at sites of acantholysis? Can one find C3 
deposition in the Fab antibody studies? 
ScHILTZ: That is an experiment that should be done. There is 
evidence, as you are aware, that certain proteolytic enzymes can cleave 
some complement components directly. 
PROVOST: I th ink that the fact that Fab fragments produce acan-
tholysis is good evidence that complement is not involved. 
ScHILTZ: I agree that complement is not required to produce acan-
tholysis. However, released or activated proteases may generate com-
plement reaction products, thus explaining their presence only within 
the lesion. 
BERGSTRESSER: In an attempt to extrapolate from both culture 
systems back to in vivo phenomena, I would like to know the effect of 
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returning either normal human serum or blister tluid to the organ and 
cell cu ltures. In particular, is acantholysis or ce ll separation inhibi ted? 
S INGEH: I have not done those experiments. 
BERGSTRESSER: Would you speculate as to what might happen? 
SINGEH: I would suspect that if you had the serum in high enough 
concentration you would see an inhibi tion of the acantholysis; however 
there are people who have seen acantholysis in the presence of normal 
human serum. 
SCHILTZ: Let me elaborate on what Dr. Singer said. In the experi-
ments using whole pemphigus serum a nd normal human skin, perfectly 
good acantholysis was produced. Similar results have been obtained 
with monkey and guinea pig skin. In these sytems it wou ld appear that 
the enzymes involved probably are no t serine proteases, because whole 
serum conta ins abundant a 2-macroglobulin. 
BYSTHYN: The pattern of fluorescence of single ce ll suspensions 
incubated with pemphigus antibody is anticytoplasmic rather than cell-
surface. This suggests that the stained cells were not viable. Since much 
of your data on protease activity can be explained by protease leaking 
out of dead cells rather t han, as you propose, being released by viable 
cells activated by pemphigus antibody, I wonder whether you have any 
data on the viability of the cell suspensions treated with pemphigus 
antibody. 
ScHILTZ: The fluorescence is not cytoplasmic, but it is on the cell 
surface. The cell peripheries appear brigh t ly ringed, there are no 
darkened nuclear areas and ceLls incubated with normal human IgG do 
not stain with antihuman lgG. The data are not consistent with your 
suggestion that pro teases leak out of dead cells. The kinetic experiments 
clearly showed that insoluble cellular proteins become solubilized at a 
time when the extractable int raceLlular soluble fraction remained con-
stant. Furthermore, the unique protease PAF could no t be detected in 
extracts of human epidermis, bu t appeared only in in tact epidermis or 
whole skin after culture with pemphigus lgG . Fina lly, let me make a 
rather didactic point. Although the epidermal cell suspension system 
was valuable in that it pointed to the solubilization phenomenon and 
suggested protease involvement, it is not the best system to study 
acantholysis. Instead, the explant culture system from which obtained 
PAF is more viable and reproducible and provides the definit ive acan-
tholysis endpoin t. 
GoLDYNE: In relation to protease release, is it possible that there is 
a target cell within the epidermis for the pemphigus antibody? Will all 
epidermal cells release the protease (PAF) in response to the pemphigus 
antibody? Perhaps discontinuous density gradient fractionation of tryp-
sinized epidermal cells can identify a population of cells responsible for 
the release of the protease in response to pemphigus antibody. 
SCHILTZ: It is known that the distribution of the pemphigus antigen 
in the basal cell area is different from that in the superbasal area. More 
importantly, the basal cell does not appear to be a target. It may be 
that the basal cell, at least, is not reacting, bu t those are good sugges-
tions. 
EDELSON: It has been known since the studies of Scheid et a l that 
the murine T cell antigen Thy-1 is also present on mouse epidermal 
cells. Have any of you attempted to identify a potentially pathogenic 
cross-reactivity of pemphigus antibodies with suppressor T cells? 
SINGER: We have not. 
PROVOST: In the melanoma system that you have just described, do 
you have evidence that a neutral serine proteinase is involved or could 
it be another type of antibody? 
SINGER: The only evidence is that the reaction is inhibited by 
soybean trypsin inhibitor. 
WUEPPER: How about other inhibitors? 
SINGER: We haven 't yet tried any other classes of enzyme inhibitors 
in the melanoma system. 
PRovosT: How clean and how pure is that soybean trypsin inhibitor? 
SINGEH: The soybean trypsin inhibitor we have used is the chJ·omat-
ographically pure preparation that comes from Sigma. I do not know 
how pure it is. I might stress again that we also tried a purified 
preparation of alpha-2 macroglobulin which also inhibited detachment 
of cultured mouse epidermal cells. 
PROVOST: And just as an outside observation, do not you think that 
there is too much stress being placed on alpha-2 macroglobulin and 
soybean trypsin inhibitor? 
SINGER: No, I do not think there's too much stress being placed on 
it. I think that it is evident that th is is a proteolytic mechanism; we 
agree on that, whether or not it is one enzyme or 15 enzymes. 
Nonms: Have you examined the effect of the protease on the 
integrity of IgG in the fluid phase or on the cell surface? It is intriguing 
to postulate that such proteases may be an important inhibitor of 
membrane-bound antibody-directed processes, especially in the Light of 
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its identification in melanoma cultures. This phenomenon may not be 
limited to epidermal cells or to pemphigus ant ibody. 
S INGER: I've not looked. 
NoRRIS: H ave you looked at the effect of soybean trypsin inhibitor 
on your PAF? 
ScHILTZ: No I have not. I would prefer to wait un til PAF is pure. 
However, we have shown that this inhibitor does not prevent pemphi-
gus an tibody-induced acantholysis in vitro. 
GI GLI: I have not heard e ither one of you talking about the specificity 
of this reaction. Have your used other tissues as targets for your 
a ntibodies beside epidermal ce lls? 
SINGER: Pemphigus serum does not cause detachment of human 
fibroblas ts. 
SCHILTZ: P emphigus IgG causes acantholysis in cultm ed guinea pig 
skin, but has no effect on guinea pig epidermal monolayers, on human 
fibroblasts or on a cell line called the BE cell line, which is derived 
from human epidermis. 
GIGLI : We ru·e looking at the initiation of a mechanism of tissue 
damage, but I think that one should keep in mind that the role of 
complement in these lesions may be one of potentiating the tissue 
damage t hTough secondaTy even ts. In this ligh t complement may be 
a mplificator of the inflammatory response. 
EPSTEIN : Will somebody comment on Lever's repor t that the pem-
phigus antibody does not necessru·ily correla te with the course of the 
disease? 
JORDO N: I would say that in at least 75% of the cases of pemphigus 
that I have seen, the antibody titer does flu ctuate with disease activity, 
t herefore it can be used as a monitor for therapy. There are, however , 
few exceptions. We have had one patient wi th very high titers who 
went into clinical remission. 
PROVOST: Our laboratory 's experience totally disagrees with Drs. 
Judd and Lever's data (Arch Dermatol, Mru·ch 1979) and, cont rru·y to 
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t heir in terpretation, we believe (O'Laughlin et al, Arch Dennatol, Dec. 
1978) there is a significant correlation between antibody titer a nd 
disease activ ity and that wi th succes ful therapy the pemphigus anti-
body titer decreases and even disapperu·s. FuTthermore, previous work 
by Drs. Jordon and Beutner (1969) and by Cru·y Feibelman in ow· 
la boratory indicate that guinea pig esophagus is an inferior substrate to 
measuTe pemphigus ant ibody titers. In our hands, 25% of our clinically 
active, histologically a nd serologically proven pemphigus patients 
(monkey esophagus) fa iled to demonstrate pemphigus antibodies on 
guinea pig esophagus. 
BYSTRYN: We have h ad the opportuni ty to fo llow a lru·gc number of 
pat ients with pemphigus. In agreement with Bob Jordon, in the major-
ity of patien ts there was a good correlation between the activity of 
pemphigus and the t iter of in tercellul ru· (IC) antibodies. H owever, we 
also found th t 5-15% of patients continue to have high t iters of IC 
ant ibodies in the absence of clinical activity and when they ru·e not 
undergoing therapy. 
JORDON : Are you using monkey esophagus as ant igen? 
BvsTRYN: This is another problem. We use monkey, guinea pig, a nd 
human skin , and find that it is true that there are species to species 
differences in some cases. 
PROVOST: In our experience, using monkey esophagus as the sub-
strate, we have not detected a proven pemphigus patient who has 
persisted in demonstrating high t iter pemphigus a ntibody without 
therapy, in the a bsence of clinical disease. I would recommend t hat you 
absorb these sera with blood group substance and send the sera to Dr. 
John Schiltz so that he may test them in his system to ee whether or 
not they induce acantholysis. 
BvSTRYN: All of the sera we tested has been tested against monkey 
esophagus and this phenomenon can be seen with monkey esophagus 
as a substrate. 
